Capricor Therapeutics Inc. (NASDAQ: CAPR) Stock Information | RedChip
Image

ASK REDCHAT ANYTHING ABOUT CAPRICOR THERAPEUTICS INC.

Capricor Therapeutics Inc. (NASDAQ: CAPR)
Listen to this Section


$19.46
-0.0430 ( -0.22% ) 382.4K

Capricor Therapeutics Inc is a United States-based biotechnology company focused on the discovery, development, and commercialization of first-in-class biological therapies for the treatment of diseases, with a focus on Duchenne muscular dystrophy and other medical conditions. The company's development stage product pipeline includes CAP-1002, for Duchenne Muscular Dystrophy Program and COVID-19 Program; CDC-Exosomes (CAP-2003); and Exosome-mRNA vaccine.

Clinical Trial Pipeline Stages


Drug Name Stage
CAP-1002DetailsCOVID-19 Failed

Market Data


Open $19.46
Previous Close $19.50
Volume 382.4K
Market Cap $1.13B
Day Range $19.03 - $20.06
52 Week Range $4.30 - $40.37
Shares Outstanding 57.91M
Change % -0.22%
Net Change ▼ -0.0430
Insider Ownership 0.24%
Exchange NASDAQ
SectorHealthcare
IndustryBiotechnology: Pharmaceutical Preparations
IPO Year2002
CountryUnited States

Insider Ownership Transactions

Total Amount Purchased: 1,783,668.00

Date Type Amount Purchased Purchaser
2024-09-24 Buy 2798507.00 Nippon Shinyaku Co Ltd
2024-08-09 Sale -34000.00 Musket David B
2024-04-25 Sale -30000.00 COLLIER EARL M JR
2024-04-24 Sale -16156.00 Musket David B
2024-01-04 Sale -80000.00 Krasney Karen
2024-01-04 Sale -85000.00 Bergmann Anthony
2024-01-04 Sale -29250.00 Auwaerter Paul Gisbert
2024-01-04 Sale -29250.00 Sabar Karimah Es
2024-01-04 Sale -29250.00 DUNBAR GEORGE W JR
2024-01-04 Sale -29250.00 COLLIER EARL M JR

SEC Filings


Form Type Description Pages Date
4 Insider transactions 1 Apr 03, 2026
4 Insider transactions 1 Apr 01, 2026
4 Insider transactions 1 Apr 01, 2026
4 Insider transactions 1 Apr 01, 2026
pre Proxies and info statements 19 Mar 31, 2026
4 Insider transactions 1 Mar 27, 2026
10-k Annual reports 91 Mar 17, 2026
8-k 8K-related 14 Mar 12, 2026
8-k 8K-related 14 Mar 10, 2026
schedule Other 3 Feb 26, 2026

Latest News